Retension Pharmaceuticals, Inc.
Pharmaceutical company · Mclean, Virginia, United States
Retension Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Mclean, Virginia, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2025.
Retension Pharmaceuticals at a glance
What does Retension Pharmaceuticals do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $12.3 million sold (2025).
Frequently asked questions about Retension Pharmaceuticals
Where is Retension Pharmaceuticals headquartered?
Retension Pharmaceuticals, Inc. is headquartered in Mclean, Virginia, United States.
What does Retension Pharmaceuticals do?
Retension Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Retension Pharmaceuticals founded?
The earliest incorporation on record for Retension Pharmaceuticals, Inc. is in 2023, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences